Tcr2 Therapeutics Inc (TCRR)
Sector • Healthcare Industry • Biotechnology & Pharmaceuticals |
Industry • Biotechnology & Pharmaceuticals |
Sector • Healthcare |
News
Between many businesses, the TCRR published also the fourth quarter of 2022 effort
released operating deficit of $-31.103 millions, in the financial interval ending September 30 2022
, decline in the operating conduct all over fiscal period ending second quarter of 2022
The company announced operating deficit in the first quarter of 2022